Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foundry Therapeutics is a biotechnology company dedicated to the discovery and development of novel therapies for immunological and inflammatory diseases. Launched by the incubator Foresite Labs, the company leverages a data-driven approach to identify and validate genetic drivers of disease. By integrating large-scale human genetics with advanced biological insights, Foundry Therapeutics aims to create precision medicines that address significant unmet needs in the autoimmune space. The company's strategy focuses on translating complex genomic data into actionable therapeutic programs, primarily utilizing small molecule modalities to modulate specific immune pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foundry Therapeutics.